Lubbock patient is among the first in Texas to receive non-invasive liver cancer treatment - KCBD

The technology, called the Edison System, arrived in West Texas through UMC's partnership with the Texas Tech University Health Sciences Center's Rural Cancer Collaborative. Histotripsy destroys liver cancer cells without surgery, incisions, needles, or radiation. Instead, the device sends focused, high-frequency ultrasound into an active tumor, forming microscopic bubbles that liquefy the cancerous tissue from the inside out.

The FDA approved the technology in 2023, and Cruz's treatment marks its arrival in Lubbock specifically. For a region where cancer patients have often had to travel to bigger cities like Dallas or Houston for cutting-edge care, having this option at UMC changes the calculus. The Rural Cancer Collaborative exists to close exactly that kind of gap for people across West Texas who live hours from major medical centers.

For liver cancer patients here, this means a path to treatment that skips the incisions, the recovery time tied to surgery, and the radiation exposure of other options. It also means Texas Tech's health science partnerships are putting Lubbock on the map for advanced cancer care, not just training future doctors. Patients who might have faced a long drive and a long recovery now have a local option that leaves no scar at all.

A man walked out of UMC cancer-free without a single incision made.